Meyka Pro banner
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (TMO) Stock Overview

Explore Thermo Fisher Scientific Inc.’s financial performance, market position, analyst ratings, and future outlook.

TMO●NYSE
HealthcareMedical - Diagnostics & Research
$717.71
$0.49(0.07%)
U.S. Market opens in 0h 56m

Thermo Fisher Scientific Inc. (TMO)

Meyka AI Score

Z

Key Financials

Market Cap265.9B
P/E Ratio37.77
EPS (TTM)$23.16
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$733.10
3 Months$755.32
1 Year Target$551.09

TMO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Thermo Fisher Scientific Inc. (NYSE: TMO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Thermo Fisher Scientific Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TMO on the NYSE shows an RSI of 60.04, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $551.09 for the NYSE listing.

Key metrics behind Thermo Fisher Scientific Inc.'s NYSE-traded stock include a P/E ratio of 37.77 and a market capitalization of 265.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TMO on the NYSE.

Price Performance (NYSE: TMO)

1-Day Change
-0.07%
5-Day Change
7.25%
1-Month Change
9.07%
3-Month Change
18.63%
6-Month Change
58.57%
Year-to-Date (YTD) Change
23.86%
1-Year Change
22.37%
3-Year Change
61.23%
5-Year Change
13.66%
All-Time (Max) Change
56861.11%

Contact Information

781 622 1000
168 Third Avenue, Waltham, MA, 02451

Company Facts

1,250,000 Employees
IPO DateMar 17, 1980
CountryUS
Actively Trading

Frequently Asked Questions